Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, +45

The Lancet

Hematological MalignancyNeuro-oncologyTreatment StrategiesMedicineStandard Temozolomide Therapy +11

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET

Norbert Galldiks, Veronika Dunkl, Gabriele Stoffels, +16

European Journal of Nuclear Medicine and Molecular Imaging

Positron Emission TomographyNeuro-oncologyOncologic ImagingMedicinePet-mri +11

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O⁶-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

Ulrich Herrlinger, Niklas Schäfer, Astrid Weyerbrock, +33

Journal of Clinical Oncology

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma

Agnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger, +9

Journal of Clinical Oncology

Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET

Sied Kebir, Rolf Fimmers, Norbert Galldiks, +11

Clinical Cancer Research

11C–MET PET/MRI for detection of recurrent glioma

Cornelius Deuschl, Julian Kirchner, Thorsten D. Poeppel, +12

European Journal of Nuclear Medicine and Molecular Imaging

Positron Emission TomographyRecurrent GliomaEngineeringOncologic ImagingMedical Imaging +8

Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors

Niklas Schäfer, Gerrit H. Gielen, Laurèl Rauschenbach, +10

Journal of Translational Medicine

Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma

Roman Reinartz, Shanshan Wang, Sied Kebir, +23

Clinical Cancer Research

Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma

Sied Kebir, Zain Khurshid, Florian Gaertner, +7

Oncotarget

Vemurafenib for Leptomeningeal Melanomatosis

Niklas Schäfer, Björn Scheffler, Moritz Stuplich, +10

Journal of Clinical Oncology

Leptomeningeal MelanomatosisMelanomaHistopathologyPathologyDermatology +1